Trial · NCT05219487
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Decrement on repetitive nerve stimulation | Baseline | Change in the percent decrement of the compound muscle action potential amplitude assessed using 3 Hz repetitive nerve stimulation (RNS) of the spinal accessory nerve compared to historical controls. If CMAP amplitude is absent at spinal accessory nerve, SMA, ulnar CMAP will be used to assess NMJ transmission. |
| Secondary | Six Minute Walk Test (6MWT) Total Distance | Baseline | The score difference between groups stratified using a 10% decrement cutoff |
| Secondary | Six Minute Walk Test Difference in Distance Between the First and Final minute | Baseline | The score difference between groups stratified using a 10% decrement cutoff |
| Secondary | Modified Spinal Muscular Atrophy Function Rating Scale (SMA-FRS) | Baseline | The score difference between groups stratified using a 10% decrement cutoff (scale 0-40, higher score is better). |
| Secondary | Revised Upper Limb Module (RULM) | Baseline | The score difference between groups stratified using a 10% decrement cutoff (scale 0-37, a higher score is better) |
| Secondary | Hammersmith Functional Rating Scale (HFMSE) | Baseline | The score difference between groups stratified using a 10% decrement cutoff (0-66, a higher score is better |
| Secondary | Fatigue Severity Scale (FSS) | Baseline | The score difference between groups stratified using a 10% decrement cutoff (9-63, the higher the score the higher the fatigue) |
| Secondary | Children's Hospital of Philadelphia - Adult Test of Neuromuscular Disorders (CHOP-ATEND) | Baseline | The score difference between groups stratified using a 10% decrement cutoff analyses (0-52, a higher score is better) |
| Secondary | Strength Measure using Hand Held Dynamometry | Baseline | Strength measurements of of bilateral shoulder abduction, elbow flexion, elbow extension, hip flexion, hip abduction, hip adduction, knee flexion and knee extension. The score difference between groups stratified using a 10% decrement cutoff analyses. |
| Secondary | Ulnar Compound Muscle Action Potential (Ulnar -CMAP) | Baseline | The difference in amplitudes between groups stratified using a 10% decrement cutoff |
| Secondary | Motor Unit Number Estimation (MUNE) | Baseline | Ulnar MUNE using modified multipoint technique. The difference in MUNE score between groups stratified using a 10% decrement cutoff |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05219487/registered